Current landscape and future directions of biomarkers for predicting responses to immune checkpoint inhibitors

about

Current landscape and future directions of biomarkers for predicting responses to immune checkpoint inhibitors

Item

http://www.wikidata.org/entity/Q56890243

description

article

@en

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Current landscape and future d ...... o immune checkpoint inhibitors

@en

Current landscape and future d ...... o immune checkpoint inhibitors

@nl

type

Item

label

Current landscape and future d ...... o immune checkpoint inhibitors

@en

Current landscape and future d ...... o immune checkpoint inhibitors

@nl

prefLabel

Current landscape and future d ...... o immune checkpoint inhibitors

@en

Current landscape and future d ...... o immune checkpoint inhibitors

@nl

P1476

Current landscape and future d ...... o immune checkpoint inhibitors

@en

P2093

Fen Zhao

http://www.w3.org/2001/XMLSchema#string

Jinming Yu

http://www.w3.org/2001/XMLSchema#string

Yingming Zhu

http://www.w3.org/2001/XMLSchema#string

Zhenxiang Li

http://www.w3.org/2001/XMLSchema#string

P2860

Mutational heterogeneity in cancer and the search for new cancer-associated genes

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Inflammation and cancer

Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial.

The blockade of immune checkpoints in cancer immunotherapy

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

PD-1 and its ligands in tolerance and immunity

P304

2475-2488

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/CMAR.S167400

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30122997

http://www.w3.org/2001/XMLSchema#string

P932

6086110

http://www.w3.org/2001/XMLSchema#string